AlzChem Group AG provided earnings guidance for the fiscal year 2020. The company now expects to generate slightly higher consolidated sales of approximately EUR 379 million in fiscal year 2020 compared to the previous year 2019: EUR 376.1 million; last forecast: stable to slightly declining. The reasons for the very positive development are the recovery of the overall markets, in particular the strong increase in demand from the pharmaceutical industry and the automotive sector.